105 related articles for article (PubMed ID: 1775608)
1. Depression as a prognostic factor for pharmacological treatment of cocaine dependence.
Ziedonis DM; Kosten TR
Psychopharmacol Bull; 1991; 27(3):337-43. PubMed ID: 1775608
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
3. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy improves treatment outcome in depressed cocaine addicts.
Ziedonis DM; Kosten TR
J Psychoactive Drugs; 1991; 23(4):417-25. PubMed ID: 1813613
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
Kosten TR; Morgan CM; Falcione J; Schottenfeld RS
Arch Gen Psychiatry; 1992 Nov; 49(11):894-8. PubMed ID: 1444728
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics.
Ziedonis D; Richardson T; Lee E; Petrakis I; Kosten T
Psychopharmacol Bull; 1992; 28(3):309-14. PubMed ID: 1480735
[TBL] [Abstract][Full Text] [Related]
7. Amantadine and desipramine in the treatment of cocaine abusing methadone maintained patients.
Kosten TR; Morgan CH; Schottenfeld RS
NIDA Res Monogr; 1990; 105():510-1. PubMed ID: 1876103
[No Abstract] [Full Text] [Related]
8. Treating cocaine abusing methadone maintenance patients with desipramine.
Kosten T; Gawin F; Schumann B
NIDA Res Monogr; 1988; 81():237-41. PubMed ID: 3136366
[TBL] [Abstract][Full Text] [Related]
9. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence.
Leal J; Ziedonis D; Kosten T
Drug Alcohol Depend; 1994 Mar; 35(1):31-5. PubMed ID: 8082553
[TBL] [Abstract][Full Text] [Related]
10. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.
Margolin A; Avants SK; Kosten TR
Am J Drug Alcohol Abuse; 1995 Nov; 21(4):469-81. PubMed ID: 8561098
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
Batki SL; Manfredi LB; Jacob P; Jones RT
J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
[TBL] [Abstract][Full Text] [Related]
13. Desipramine treatment of alcoholism.
Mason BJ; Kocsis JH
Psychopharmacol Bull; 1991; 27(2):155-61. PubMed ID: 1924663
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and behavioral treatments of cocaine dependence: controlled studies.
O'Brien CP; Childress AR; Arndt IO; McLellan AT; Woody GE; Maany I
J Clin Psychiatry; 1988 Feb; 49 Suppl():17-22. PubMed ID: 3276670
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine.
Kolar AF; Brown BS; Weddington WW; Haertzen CC; Michaelson BS; Jaffe JH
Int J Addict; 1992; 27(7):849-68. PubMed ID: 1319961
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine treatment of cocaine abuse in heroin addicts.
Pollack MH; Rosenbaum JF
J Clin Psychiatry; 1991 Jan; 52(1):31-3. PubMed ID: 1988415
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.
Halikas JA; Crosby RD; Pearson VL; Graves NM
Clin Pharmacol Ther; 1997 Jul; 62(1):89-105. PubMed ID: 9246023
[TBL] [Abstract][Full Text] [Related]
18. DHEAS and POMS measures identify cocaine dependence treatment outcome.
Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
[TBL] [Abstract][Full Text] [Related]
19. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
20. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy.
Carroll KM; Nich C; Rounsaville BJ
J Nerv Ment Dis; 1995 Apr; 183(4):251-9. PubMed ID: 7714514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
